AstraZeneca and Hall & Partners are delighted to have won the ‘Best Use of Innovation’ award in the 2021 BHBIA BOBI Awards. The healthcare research project, which leveraged innovative technology to speed insights to action across a globally distributed team, was initially recognised as ‘Highly Commended’ in the ‘Best use of Innovation’ category.
The BHBIA BOBI judges described the winning healthcare innovation project as “never seen before.” They referred to how the partnership with AstraZeneca brought the “market research to life” on what was described as a “topical need” that was “well demonstrated.”
We are thrilled to be recognised alongside AstraZeneca for this prestigious innovation award – I am incredibly proud of our team. This technology-led comms testing approach allowed for insight-led decisions to be made confidently at speed, bringing trusted messages to patients and physicians.
Strategy Director, Hall & Partners
‘Best use of innovation’ submission summary
AstraZeneca had achieved unprecedented clinical trial outcomes, which accelerated their launch plan by two years. The leading pharmaceutical and biotechnology company needed to test and optimise their global launch campaign quickly. Recognising the challenges – a rapidly approaching launch, tight timings, and diverse stakeholder needs, alongside the background of virtual working due to COVID-19 – AstraZeneca challenged Hall & Partners to reimagine the insights sharing and synthesis process.
Hall & Partners constructed an innovative approach using Enlyta Insights, which brought agility, efficiency, and alignment, letting AstraZeneca make insight-led decisions confidently and quickly.
